de Groot Tom M, van der Linden Lotte R, Bedi Angad D S, Lucaciu Andreea A, Jang Caleb C, Groot Olivier Q, Doornberg Job N, Jutte Paul C, Lozano-Calderon Santiago A, Schwab J H
Department of Orthopedic Surgery, Massachusetts General Hospital, Boston, MA, USA.
Department of Orthopedic Surgery, University Medical Center Groningen, Groningen, The Netherlands.
J Bone Oncol. 2025 Aug 5;54:100707. doi: 10.1016/j.jbo.2025.100707. eCollection 2025 Oct.
Social Determinants of Health (SDOH) are non-medical factors that influence health, which have gained recognition across medical disciplines. Their impact on survival and disease presentation of patients with metastatic bone disease (MBD) remains unexplored.
This retrospective observational study included 712 undergoing surgery for symptomatic long-bone metastases patients between 2013 and 2022. SDOH were evaluated using Cox Proportional hazards regression for post-operative survival. A multivariate logistic regression analysis was performed to identify associated factors for clinical presentation with a completed pathologic fracture.
The median overall survival was 264 days (IQR 74-772). Clinical presentation with a pathologic fracture as the initial symptom of metastatic bone disease (MBD) was observed in 15 % of patients (106/712).SDOH factors played a significant role in clinical presentation. Patients with secondary insurance coverage were substantially less likely to present with a pathologic fracture (OR 0.26, 95 % CI 0.14-0.49; p < 0.01). In a sub-analysis of the most common tumors (breast, renal, and lung cancer patients; n = 353), attending college was associated with a significantly lower likelihood of presenting with a pathologic fracture as the initial symptom of metastatic bone disease (OR 0.54, 95 % CI 0.30-0.95; p = 0.03).
This study suggests that unfavorable SDOH factors are associated with decreased post-operative survival and a higher likelihood of initial clinical presentation with a completed pathological fracture. Incorporating social determinants into comprehensive care strategies for individuals with MBD may guide targeted interventions and optimize patient management to improve outcomes.
健康的社会决定因素(SDOH)是影响健康的非医学因素,已在各医学学科中得到认可。它们对转移性骨病(MBD)患者的生存和疾病表现的影响尚待探索。
这项回顾性观察性研究纳入了2013年至2022年间712例因有症状的长骨转移而接受手术的患者。使用Cox比例风险回归评估SDOH对术后生存的影响。进行多因素逻辑回归分析以确定出现完全病理性骨折临床表现的相关因素。
中位总生存期为264天(四分位间距74 - 772天)。15%的患者(106/712)以病理性骨折作为转移性骨病(MBD)的初始症状就诊。SDOH因素在临床表现中起重要作用。有二级保险的患者出现病理性骨折的可能性显著降低(比值比0.26,95%置信区间0.14 - 0.49;p < 0.01)。在对最常见肿瘤(乳腺癌、肾癌和肺癌患者;n = 353)的亚分析中,上过大学与作为转移性骨病初始症状出现病理性骨折的可能性显著降低相关(比值比0.54,95%置信区间0.30 - 0.95;p = 0.03)。
本研究表明,不利的SDOH因素与术后生存率降低以及初始临床表现出现完全病理性骨折的可能性增加有关。将社会决定因素纳入MBD患者的综合护理策略中,可能有助于指导有针对性的干预措施并优化患者管理,以改善治疗结果。